ACE and Arrhythmia: The CAPRICORN study further described powerful anti‐arrhythmic effects of carvedilol, as it was able to suppress postinfarction arrhythmias even in patients already treated with an angiotensin converting enzyme (ACE) inhibitor (McMurray et al., 2005).